Team:Groningen/Notebook/Modeling 12June2012
From 2012.igem.org
![](https://static.igem.org/mediawiki/2012/a/ad/Groningen2012_AD_20120802_SmallCog.png)
![](https://static.igem.org/mediawiki/2012/a/ad/Groningen2012_AD_20120802_SmallCog.png)
![](https://static.igem.org/mediawiki/2012/a/ad/Groningen2012_AD_20120802_SmallCog.png)
![](https://static.igem.org/mediawiki/2012/a/ad/Groningen2012_AD_20120802_SmallCog.png)
![](https://static.igem.org/mediawiki/2012/a/ad/Groningen2012_AD_20120802_SmallCog.png)
![](https://static.igem.org/mediawiki/2012/a/ad/Groningen2012_AD_20120802_SmallCog.png)
![](https://static.igem.org/mediawiki/2012/4/41/Groningen_2012_logoFW.png)
![](https://static.igem.org/mediawiki/igem.org/1/17/IGEM_basic_Logo_white_stylized.png)
Started research into metabolic control analysis (MCA). FBA has limited potential as,
(1) it may only indicate a increase or decrease in lycopene production due to the wide range in fluxes,
and (2) it would require precise concentration measurements as a starting point.
So, MCA may...may...offer a more accurate description of the pathways.
Back to notebook